Skip to main content
Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.849
-0.014 (-1.59%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Vivos Therapeutics Revenue

In the year 2025, Vivos Therapeutics had annual revenue of $17.44M with 16.05% growth. Vivos Therapeutics had revenue of $3.82M in the quarter ending December 31, 2025, with 3.41% growth.

Revenue (ttm)
$17.44M
Revenue Growth
+16.05%
P/S Ratio
0.66
Revenue / Employee
$66,576
Employees
262
Market Cap
11.46M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202517.44M2.41M16.05%
Dec 31, 202415.03M1.23M8.91%
Dec 31, 202313.80M-2.22M-13.87%
Dec 31, 202216.02M-861.00K-5.10%
Dec 31, 202116.89M3.82M29.23%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
IRIDEX 52.68M
Trinity Biotech 48.57M
Lifeward 22.03M
Biomerica 4.33M
Tenon Medical 3.94M
Sintx Technologies 1.02M
iTonic Holdings 523.03K
Nexalin Technology 301.65K
Revenue Rankings

VVOS News

More News